KORU Medical Systems, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $41.1M | $33.6M | $28.5M | $27.9M | $23.5M |
| Cost of revenue | $15.5M | $12.3M | $11.8M | $12.5M | $9.7M |
| Gross profit | $25.6M | $21.3M | $16.7M | $15.4M | $13.8M |
| Selling, general & administrative | $23.4M | $21.6M | $20.4M | $20.6M | $17.9M |
| Research and development | $4.4M | $5.3M | $5.7M | $5.0M | $2.5M |
| Operating expenses | $28.6M | $27.8M | $27.0M | $26.1M | $20.8M |
| Operating income | -$3.0M | -$6.4M | -$10.3M | -$10.8M | -$7.0M |
| Pretax income | -$2.6M | -$6.1M | -$9.8M | -$10.7M | -$6.4M |
| Income tax expense | $21,890 | $2,893 | $4.0M | -$2.0M | -$1.8M |
| Net income | -$2.6M | -$6.1M | -$13.7M | -$8.7M | -$4.6M |
| Balance Sheet | |||||
| Cash and equivalents | $8.9M | $9.6M | $11.5M | $17.4M | $25.3M |
| Current assets | $20.0M | $19.1M | $20.3M | $29.8M | $37.3M |
| Total assets | $28.2M | $27.2M | $28.5M | $42.3M | $41.3M |
| Current liabilities | $8.2M | $7.2M | $4.5M | $7.0M | $4.8M |
| Total liabilities | $11.2M | $10.4M | $8.1M | $11.0M | $4.8M |
| Stockholders' equity | $17.0M | $16.8M | $20.4M | $31.3M | $36.5M |
| Cash Flow Statement | |||||
| Cash from operations | $462,405 | -$319,718 | -$4.9M | -$5.4M | -$4.3M |
| Depreciation and amortization | $810,500 | $888,473 | $870,390 | $587,137 | $463,130 |
| Stock-based compensation | $2.7M | $2.6M | $2.8M | $3.1M | $2.7M |
| Capital expenditure | $932,517 | $1.3M | $782,949 | $2.8M | $346,178 |
| Free cash flow | -$470,112 | -$1.6M | -$5.7M | -$8.2M | -$4.7M |
Shares outstanding 45.9M · Free float 81.9%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.